Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00421798 · ClinicalTrials.gov registry record
Rapid Characterization of Paucibacillary TB Along Tex/Mex Border
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 780
- Enrollment target
NCT00421798 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 780 participants.
The verdict
NCT00421798 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 780 participants
- Enrollment target
Study Summary
This study will test a method of detecting tuberculosis-causing bacteria that are resistant to current medication treatments. Blood samples will be collected from patients from 3 sites and 3 mainly Hispanic populations in Texas, Mexico, and Colombia. Up to 780 males and females, ages 18-85 years, will participate. The study population will consist of 390 people with any of 3 forms of tuberculosis (TB) and 390 people who are either healthy or with a disease initially thought to be one of these 3 forms of TB but then ruled out. Volunteers will only be contacted, invited to participate and interviewed at the beginning of their evaluation for possible TB.The study team will follow up with the health department to determine if the volunteer was indeed diagnosed with TB, and with the laboratory to determine the results of TB tests at diagnosis and during the course of treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00421798
The ClinicalTrials.gov registry entry for NCT00421798 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00421798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00421798 about?
NCT00421798 is a clinical study titled "Rapid Characterization of Paucibacillary TB Along Tex/Mex Border". This study will test a method of detecting tuberculosis-causing bacteria that are resistant to current medication treatments. Blood samples will be collected from patients from 3 sites and 3 mainly Hispanic populations in Texas, Mexico, and Colombia. Up to 780 males and females, ages 18-85 years, wi...
What is the current status of trial NCT00421798?
This trial is currently completed. The enrollment target is 780 participants. The study started on 2007-01. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00421798?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.